Surviving an FDA Sponsor Inspection - Training for Success


Instructor: Stephen Schwartz
Product ID: 704516
Training Level: Advanced

  • Duration: 105 Min
This training program will review a case study derived from actual inspections wherein FDA performed a sponsor site inspection having already audited three of the investigator sites. FDA was aware from these site audits of potential serious noncompliance issues. The course will also discuss Sponsor/CRO/investigator relationship issues from these three site audits.
Last Recorded Date: Aug-2019


1 Person Unlimited viewing for 6 month info Recorded Link and Ref. material will be available in My CO Section
(For multiple locations contact Customer Care)

1 USB is for usage in one location only. info CD/USB and Ref. material will be shipped within 15 business days
(For multiple locations contact Customer Care)



Customer Care

Fax: +1-650-362-2367

Email: [email protected]

Read Frequently Asked Questions

Why Should You Attend:

The sponsor clinical operations staff guided the sponsor and investigator site staff through the FDA inspection/audit process. The result was a passed FDA sponsor inspection and approved NDA. There were no FDA warning letters issued to any investigators.

This webinar will discuss how seemingly insurmountable obstacles to a successful FDA sponsor inspection were resolved and how you can apply these lessons to your next FDA sponsor inspection.

Areas Covered in the Webinar:

  • FDA inspectional procedures; What sponsor staff are audit targets and how FDA inspections are performed
  • Sponsor SOP and TMF options that work and do not work toward complying with FDA documentation requirement
  • FDA sponsor inspection objectives and perspectives
  • Typical and common FDA questions and how not to respond
  • The impact of CRO contractual delegation of project responsibilities on sponsor regulatory obligations
  • Audit of sponsor records and training of sponsor staff as a positive step in preparing for the inspection

Who Will Benefit:

  • CQA
  • Regulatory personnel
  • Clinical operations, CRA
  • Director and upper level pharma research management
  • Investigators and research management staff
  • Clinical Project Manager
  • Regulatory Affairs
  • Compliance Manager
  • Trial Master File Manager

Recently Asked Questions:

  1. For FDA inspection of sites outside of the US, what are some considerations?
  2. Can you provide some insights about the timing of the FDA inspections after submitting the NDA?
Instructor Profile:
Stephen Schwartz

Stephen Schwartz
Founder, Solaris Research Corporation

Steve Schwartz, is the founder of Solaris Research Corporation. He has a biology degree with a major in microbiology. He has 7 years of virology research in pharma, and moved into clinical research program administration for 6 years in the pharmaceutical industry. Entering the CRO industry, he performed clinical monitoring and clinical quality assurance field service using that expertise to achieve a management position at the director level over the next 10 years. 10 years of CRO experience culminated in the formation of his full service CRO in 1989 to 2008 , under the initial name of Commonwealth Clinical Research Corporation- later Solaris Research Corp. Steve has also served as the investigator for several phase four clinical trials. He has served on an academic IRB. After a brief retirement he worked as Senior Manager, Global Clinical Operations/ GCP in pharma. for 4 years until 2012. Escaping from the corporate environment he is again in retirement and continues to speak and consult to enable the sharing of his experience and expertise in CQA, regulatory affairs, and clinical operations including SOP, TMF, clinical monitoring, and best practices. Steve has designed basic and advanced CQA courses for delivery to Health Canada and US Government agencies, to the pharmaceutical industry, and to academic institutions. He has provided clinical program management, clinical monitoring, CQA auditing and regulatory consulting. Steve published a monthly electronic clinical trial conduct newsletter from 2000 to 2008.

Follow us :



Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).




6201 America Center Drive Suite 240, San Jose, CA 95002, USA

Follow Us

facebook twitter linkedin youtube


Copyright © 2021 MetricStream
Our Policies: Terms of use | Privacy

PAYMENT METHOD: 100% Secure Transaction

payment method